David A. Siegel Cv Rx, Inc. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Cv Rx, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 37,800 shares of CVRX stock, worth $365,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,800
Previous 81,000
53.33%
Holding current value
$365,148
Previous $990,000
77.58%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CVRX
# of Institutions
93Shares Held
14.9MCall Options Held
42.2KPut Options Held
32.4K-
Johnson & Johnson New Brunswick, NJ4.1MShares$39.6 Million8.12% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$19.6 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.08MShares$10.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$8.46 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT789KShares$7.62 Million0.62% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $199M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...